Navigation Links
Soligenix Reports Third Quarter 2009 Financial Results
Date:11/13/2009

penses for the first nine months of 2009 were approximately $1.7 million, compared to $1.8 million for the first nine months of 2008.

About Soligenix, Inc.

Soligenix, Inc. (Soligenix), formerly known as DOR BioPharma, Inc., is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of GI GVHD, a common and potentially life-threatening complication of hematopoietic cell transplantation. orBec® is currently the subject of a confirmatory Phase 3 clinical trial for the treatment of acute GI GVHD and an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in the prevention of acute GVHD. Soligenix also expects to begin an NIH-supported Phase 1/2 clinical trial of SGX201 in radiation enteritis in the second half of 2009. Additionally, Soligenix has a Lipid Polymer Micelle (LPM(TM)) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis.

Through its Biodefense Division, Soligenix is developing biomedical countermeasures pursuant to the Project BioShield Act of 2004. Soligenix's lead biodefense product in development is a recombinant subunit vaccine called RiVax(TM) which is designed to protect against the lethal effects of exposure to ricin toxin. RiVax(TM) has been shown to be well tolerated and immunogenic in a Phase 1 clinical trial in normal volunteers. RiVax(TM) will also be the subject of a recent $9.4 million NIH grant received by the Company supporting development of new heat stable vaccines.

For further information regarding Soligenix, Inc., please visit the Company's website at www.solig
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX
2. Soligenix Appoints Robert J. Rubin, MD, to its Board of Directors
3. Soligenix to Present at 8th Annual BIO Investor Forum
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. QMed, Inc. Reports July Medicare SNP Enrollments
6. Phlo Affiliate Reports Expanded Coverage to Oregon Border
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
9. Carrington Reports Second Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... SAO PAULO , June 2, 2015   ... leader in biosimilars, today announced that its partner, Celltrion – ... ANVISA – the National Health Surveillance Agency in ... first biosimilar monoclonal antibody approved for use in ... by Hospira. Hospira also markets and sells biosimilar infliximab ...
(Date:6/2/2015)... , June 2, 2015   BioClinica ® , ... provider, today announced that David Peters , an ... Executive Vice President and Chief Financial Officer (CFO) and ... Peters brings more than 25 years of financial ... "David has extensive and deep knowledge in all areas ...
(Date:6/2/2015)... June 2, 2015  RXi Pharmaceuticals Corporation ... focused on discovering and developing innovative therapies ... ophthalmology, today announced that Dr. Pamela Pavco ... at the 23 rd World Congress ... will include in-depth presentations by world-class clinicians ...
(Date:6/2/2015)... Ohio , June 2, 2015 GOJO, ... pledged its commitment to antibiotic stewardship at the White ... human and animal health organizations and stakeholders at the ... five years to slow the emergence of antibiotic-resistant bacteria, ... antibiotics, and prevent the spread of resistant infections. ...
Breaking Biology Technology:ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5BioClinica Names David Peters New Chief Financial Officer 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4
... -- API Software, Inc. announced today ... to implement the majority of APIs suite of ... hospital. The solution will include Payrollmation time and ... Navigator human resources software. , ,The hospital is ...
... answer to the long-standing riddle of whether the Earth's ice ... is emerging from the glacial deposits found in the high ... to gauge the effects of cosmic rays on minerals found ... ago, a group of scientists from the University of Wisconsin-Madison ...
... the greatest surnames of our period. Trump, a superb name brand ... is also my hero. Don is a savvy global marketer with ... Apprentice", a reality TV shows series, wants to own the term ... last pillars of civility of our business protocols is still a ...
Cached Biology Technology:Glacial records depict ice age climate in synch worldwide 2Glacial records depict ice age climate in synch worldwide 3"You're fired!" Trump wants trademark rights 2
(Date:5/21/2015)... DALLAS , May 21, 2015 ... report, "Thermal Imaging Market by Solutions (Hardware, Software, Services), ... Veterinary, Automotive & others), by End-Users (Military & ... published by MarketsandMarkets, Thermal Imaging Market is expected ... $9998.9 Million by 2020, at a Compound Annual ...
(Date:5/20/2015)... May 20, 2015 ... has announced the addition of the  ... Iris Recognition Market"  report to their ... research service analyses trends in the ... and commercial sectors, globally. Despite hardware ...
(Date:5/19/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... The aging baby boomers and subsequent generations will be ... help them live longer, healthier and more active lives than ... Food Technologists, Wellness 12 meeting. There are 78 million ... born from Jan. 1, 1946, to Dec. 31, 1964 in ...
... atypical antipsychotic drug improved survival in a mouse model ... month. The result offers promise for a common and ... for treatment. Mice treated with small doses of ... weight when given an exercise wheel and restricted food ...
... of "improved cookstoves" (ICs) and traditional mud stoves has ... of the worrisome "black carbon," or soot, particles that ... traditional mud stoves or open-cook fires. The report, which ... cooking technology in the developing world, appears in ACS, ...
Cached Biology News:Antipsychotic drug may be helpful treatment for anorexia nervosa 2Antipsychotic drug may be helpful treatment for anorexia nervosa 3
Packaging: package with 500 l Patent/trademark/license (electronic): (r) Registered trademark of Molecular Probes...
... purification system, 100-120 V, is used for ... focusing (IEF). The system includes both the ... focusing chambers, chassis, harvesting apparatus, cooling finger, ... 3-10), 60 ml syringe, colored protein sample, ...
...
... B-Phycoerythrin Labeling Kit - NH2 is ... antibody for immunostaining and cellular proteins for ... kit, has succinimidyl group (NHS), and can ... groups of IgG or other proteins without ...
Biology Products: